Menu

地拉罗司2020年进入医保了吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

(Enrig) is used to treat chronic iron overload caused by frequent blood transfusions (monthly administration of concentrated red blood cells ≥7 mL/kg) in patients with beta-thalassemia older than 6 years old. Will deferasirox enter medical insurance in 2020?

In 2010, Deferasirox (Enreg) was approved for marketing in China. According to Medical Partner Travel, Deferasirox (Enreg) has not been officially included in medical insurance and is a self-pay drug for patients.

After Deferasirox (Enrego) was launched, the price in China was relatively high, with a box costing about $2,000. For an ordinary person weighing 60kg, the cost of taking Deferasirox (Enrige) for a month is more than about $24,000. It can be seen that it is difficult for ordinary families to accept this price. Fortunately, Novartis of Switzerland has imported deferasirox (Enrego) from India, with a specification of 400mg*30 tablets/box and a price of about $700. The specification of Deferasirox (Enrego) produced by Indian pharmaceutical factory is 500*30 tablets/box, and the price is about 500$. Due to the fluctuation of exchange rate, the price will be different. Please consult the medical companion for the specific price. Patients can choose to purchase different versions of deferasirox according to their own circumstances.

In addition, the recommended dose of deferasirox (Enrige) is 20mg/kg. For patients who receive monthly transfusions of more than 14 mL/kg of packed red blood cells (ie, more than 4 units/month in adults) and who need to reduce excess iron exposure, a starting dose of 30 mg/kg/day may be considered. For patients who receive monthly transfusions of less than 7 mL/kg of packed red blood cells (i.e., less than 2 units/month in adults) and who need to maintain body iron balance, a starting dose of 10 mg/kg/day may be considered.

The above is the medical insurance situation of Deferasirox (Enrig) provided to you by our Medical Companion Overseas Medical Consulting Service Company. Currently (Enrig) has not been included in the medical insurance in my country.

Recommended related hot articles: /newsDetail/75889.html

 

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。